Continuities and discontinuities in pharmaceutical treatment and medication use among older chronically ill patients of Turkish descent in Germany: a qualitative structuring content analysis
Hürrem Tezcan-Güntekin, Rona Bird, Sema Aslan, Yagmur Kul, Özge Azman, Volkan Aykaç, Beate Klammt, Meryem Aslan, Ilknur Özer-Erdoğdu

TL;DR
This study explores medication use and barriers among older Turkish migrants in Germany, highlighting issues like polypharmacy and language barriers.
Contribution
The study provides insights into medication management challenges specific to Turkish-descent older adults in Germany.
Findings
Participants often take more than five medications daily and aim to take them regularly.
Discontinuities in medication occur due to side effects or forgetfulness.
Language barriers and physician disinterest lead to a preference for Turkish-speaking doctors.
Abstract
Polypharmacy occurs frequently among older adults and is associated with an increased risk of falls and medication-related adverse events. In particular, people with a history of migration may receive inappropriate medication due to language barriers or discrimination in healthcare. This study aims to assess the continuities, discontinuities and barriers to drug therapy in older migrants of Turkish descent in Berlin, Germany. Eleven problem-centered qualitative interviews with chronically ill older persons of Turkish descent and family caregivers were conducted and analyzed qualitatively by means of structuring content analysis. The chronically ill participants of Turkish descent predominantly take more than 5 types of medication per day and aim to take them regularly. Discontinuities emerge when medication is forgotten or intentionally omitted due to side effects. Frequent changes in…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsChronic Disease Management Strategies · Tuberculosis Research and Epidemiology · Interpreting and Communication in Healthcare
